ArticleScientific reports2021

Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity.

Hana Bavlovič Piskáčková et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.